GlassScriptPhysician profile
Francisco M Rivera
NPI 1487742037
$11,301.04
in general payments reported to CMS, 2019-2025
27 companies · $3,525 in 2025
The $3,525 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,660 · 2022: $1,754 · 2023: $1,075 · 2024: $3,288 · 2025: $3,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,696 · Travel and Lodging: $3,060 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,696.39 |
| Travel and Lodging | $3,059.87 |
| Education | $131.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,952.18 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $1,563.96 | 2021-2025 | |
| Medtronic, INC. | $1,091.36 | 2021-2025 | Corevalve Evolut R, Affera Mapping System, Reveal Linq |
| Janssen Pharmaceuticals, INC | $697.54 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $658.70 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $577.11 | 2021-2024 | Farxiga, Andexxa, Lokelma |
| Pfizer INC. | $443.58 | 2021-2025 | |
| Amgen INC. | $374.91 | 2021-2022 | |
| Abiomed | $243.81 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $221.57 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.61 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $166.09 | 2021-2022 | |
| Boston Scientific Corporation | $164.13 | 2022-2025 | General - Balloon Catheters, Avvigo Guidance System, Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $149.39 | 2022-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $128.42 | 2022-2024 | Ozempic, Rybelsus |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $117.52 | 2024 | Apretude |
| Atricure, INC. | $104.70 | 2022 | |
| Cvrx, INC. | $64.50 | 2024-2025 | Barostim Neo System |
| Altathera Pharmaceuticals LLC | $63.76 | 2023-2024 | Sotalol Hydrochloride |
| Abbott Laboratories | $63.11 | 2022 | |
| Alnylam Pharmaceuticals INC. | $59.97 | 2021-2025 | Onpattro |
| Janssen Biotech, INC. | $49.19 | 2022-2023 | Tremfya |
| Lexicon Pharmaceuticals, INC. | $46.92 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.52 | 2022-2024 | |
| Inari Medical, INC. | $24.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Tactile Systems Technology INC | $16.62 | 2023 | Flexitouch Plus, Entre Plus |
| Surmodics, INC. | $9.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.